JP Morgan Chase
IART icon

JP Morgan Chase’s Integra LifeSciences IART Stock Holding History

JP Morgan Chase’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.02M Sell
214,504
-177,964
-45% -$2.49M ﹤0.01% 3634
2026
Q1 		$3.58M Sell
392,468
-128,645
-25% -$1.41M ﹤0.01% 3627
2025
Q4 		$6.47M Sell
521,113
-30,619
-6% -$407K ﹤0.01% 3084
2025
Q3 		$7.91M Sell
551,732
-21,229
-4% -$291K ﹤0.01% 2926
2025
Q2 		$7.03M Buy
572,961
+263,229
+85% +$3.82M ﹤0.01% 2854
2025
Q1 		$6.81M Buy
309,732
+110,041
+55% +$2.59M ﹤0.01% 2891
2024
Q4 		$4.53M Buy
199,691
+113,061
+131% +$2.47M ﹤0.01% 3451
2024
Q3 		$1.57M Sell
86,630
-20,279
-19% -$470K ﹤0.01% 4179
2024
Q2 		$3.12M Sell
106,909
-45,972
-30% -$1.36M ﹤0.01% 3408
2024
Q1 		$5.42M Sell
152,881
-2,299
-1% -$91.9K ﹤0.01% 3036
2023
Q4 		$6.76M Sell
155,180
-10,593
-6% -$417K ﹤0.01% 2827
2023
Q3 		$6.33M Sell
165,773
-30,530
-16% -$1.28M ﹤0.01% 2657
2023
Q2 		$8.07M Buy
196,303
+8,602
+5% +$414K ﹤0.01% 2471
2023
Q1 		$10.8M Buy
187,701
+18,452
+11% +$1.04M ﹤0.01% 2212
2022
Q4 		$9.49M Sell
169,249
-32,703
-16% -$1.66M ﹤0.01% 2308
2022
Q3 		$8.55M Buy
201,952
+22,728
+13% +$1.16M ﹤0.01% 2286
2022
Q2 		$9.68M Buy
179,224
+24,542
+16% +$1.47M ﹤0.01% 2195
2022
Q1 		$9.94M Sell
154,682
-8,537
-5% -$562K ﹤0.01% 2379
2021
Q4 		$10.9M Buy
163,219
+20,789
+15% +$1.41M ﹤0.01% 2369
2021
Q3 		$9.75M Sell
142,430
-12,150
-8% -$858K ﹤0.01% 2409
2021
Q2 		$10.5M Buy
154,580
+15,119
+11% +$1.07M ﹤0.01% 2382
2021
Q1 		$9.63M Buy
139,461
+17,586
+14% +$1.19M ﹤0.01% 2395
2020
Q4 		$7.91M Sell
121,875
-1,298
-1% -$69.8K ﹤0.01% 2400
2020
Q3 		$5.72M Buy
123,173
+8,879
+8% +$422K ﹤0.01% 2457
2020
Q2 		$5.37M Sell
114,294
-61,574
-35% -$3.03M ﹤0.01% 2403
2020
Q1 		$7.86M Buy
175,868
+80
+0% +$4.2K ﹤0.01% 1917
2019
Q4 		$10.2M Sell
175,788
-11,298
-6% -$673K ﹤0.01% 2094
2019
Q3 		$11.2M Buy
187,086
+46,438
+33% +$2.77M ﹤0.01% 2048
2019
Q2 		$7.65M Sell
140,648
-22,445
-14% -$1.16M ﹤0.01% 2306
2019
Q1 		$9.09M Buy
163,093
+67,842
+71% +$3.46M ﹤0.01% 2131
2018
Q4 		$4.3M Sell
95,251
-181,813
-66% -$9.98M ﹤0.01% 2694
2018
Q3 		$18.3M Buy
277,064
+141,368
+104% +$8.79M ﹤0.01% 1735
2018
Q2 		$8.74M Buy
135,696
+119,945
+762% +$7.43M ﹤0.01% 2255
2018
Q1 		$871K Sell
15,751
-29,470
-65% -$1.54M ﹤0.01% 3752
2017
Q4 		$2.17M Buy
45,221
+44,025
+3,681% +$2.15M ﹤0.01% 3272
2017
Q3 		$60K Sell
1,196
-628
-34% -$32.3K ﹤0.01% 4427
2017
Q2 		$99K Sell
1,824
-121,144
-99% -$5.78M ﹤0.01% 4177
2017
Q1 		$5.18M Sell
122,968
-41,760
-25% -$1.78M ﹤0.01% 2395
2016
Q4 		$7.07M Buy
164,728
+164,684
+374,282% +$6.69M ﹤0.01% 2170
2016
Q3 		$2K Sell
44
-51,090
-100% -$2.14M ﹤0.01% 4433
2016
Q2 		$2.04M Buy
51,134
+12,340
+32% +$444K ﹤0.01% 2795
2016
Q1 		$1.31M Buy
38,794
+2,298
+6% +$71.6K ﹤0.01% 2931
2015
Q4 		$1.24M Buy
36,496
+4,410
+14% +$138K ﹤0.01% 3018
2015
Q3 		$956K Buy
32,086
+1,791
+6% +$56K ﹤0.01% 3128
2015
Q2 		$834K Buy
30,295
+113
+0.4% +$3.01K ﹤0.01% 3367
2015
Q1 		$761K Buy
30,182
+19,288
+177% +$456K ﹤0.01% 3342
2014
Q4 		$242K Buy
+10,894
New +$221K ﹤0.01% 3961
2014
Q1 		– Sell
-26,544
Closed -$518K – 3737
2013
Q4 		$518K Sell
26,544
-76,291
-74% -$1.4M ﹤0.01% 3472
2013
Q3 		$1.69M Buy
102,835
+4,766
+5% +$76.5K ﹤0.01% 2916
2013
Q2 		$1.47M Buy
+98,069
New +$1.44M ﹤0.01% 3017

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

JP Morgan Chase's IART Position: Q2 2026 in Review

JP Morgan Chase reduced its Integra LifeSciences (IART) stake by 45% in Q2 2026, selling an estimated $2.49M and leaving 214,504 shares worth $4.02M. The position accounts for ﹤0.01% of the portfolio, ranked #3634.

JP Morgan Chase first reported a position in IART in Q2 2013 and has held it in 50 quarters since. The position peaked at $18.3M in Q3 2018. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • JP Morgan Chase held 214,504 shares of Integra LifeSciences worth $4.02M as of Q2 2026.
  • JP Morgan Chase sold 177,964 Integra LifeSciences shares in Q2 2026, an estimated $2.49M.
  • Integra LifeSciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3634 holding.
  • JP Morgan Chase first reported a position in Integra LifeSciences in Q2 2013 and has held it in 50 quarters since.
  • JP Morgan Chase's Integra LifeSciences position peaked at $18.3M in Q3 2018.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.